Syndax Pharmaceuticals (SNDX) EBT Margin (2015 - 2026)
Syndax Pharmaceuticals' EBT Margin was -43.58% in Q3 2026, up 70.12 percentage points from -113.70% a year earlier and up 6.22 percentage points from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) EBT Margin (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Syndax Pharmaceuticals' EBT Margin was -55.72% through Sep 30, 2026, up 196.42 percentage points year-over-year; for FY2025, it came in at -145.26%, up 1178.98 percentage points from FY2024.
- EBT Margin shows a five-year change of +4662.85 percentage points (FY2020 to FY2025).
- In earlier years, EBT Margin was -1324.24% in FY2024 and 17.70% in FY2021 (+4825.80 pp).
- The Q3 2026 figure marks the highest quarterly EBT Margin since Q4 2021.
- Compared with a year earlier, EBT Margin has increased for six straight quarters, with an average year-over-year change of +655.47 percentage points over the last six quarters.
- Per Business Quant data, SNDX's EBT Margin in the three quarters before Q3 2026 was -49.80% (Q2 2026), -47.24% (Q1 2026) and -84.71% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 0.13% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 27.75% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 45.21% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 36.90% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 20.41% |
| 10 | Syndax Pharmaceuticals | 871.86 Mn | -849.24 Mn | 69.30 Mn | -43.58% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -43.58% |
| Jun 30, 2026 | -49.80% |
| Mar 31, 2026 | -47.24% |
| Dec 31, 2025 | -84.71% |
| Sep 30, 2025 | -113.70% |
| Jun 30, 2025 | -167.05% |
| Mar 31, 2025 | -382.08% |
| Dec 31, 2024 | -1,160.59% |
| Sep 30, 2024 | -673.26% |
| Jun 30, 2024 | -1,942.20% |
| Dec 31, 2021 | 75.72% |
| Sep 30, 2021 | -166.45% |
| Jun 30, 2021 | -6,031.66% |
| Mar 31, 2021 | -7,299.74% |
| Dec 31, 2020 | -5,365.53% |
| Sep 30, 2020 | -5,359.10% |
| Jun 30, 2020 | -4,491.56% |
| Mar 31, 2020 | -4,014.78% |
| Dec 31, 2019 | -3,679.74% |
| Sep 30, 2019 | -3,365.17% |
API Access
Syndax Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();